Associate Director
Regenxbio
At REGENXBIO Inc., my role as Associate Director of Toxicology and a board certified toxicologist (DABT) involves steering nonclinical pharmacology and toxicology studies for groundbreaking gene therapy drugs. My work is instrumental in transitioning candidates from selection to IND and BLA, showcasing my adeptness in regulatory guidelines and communication with health authorities. Serving as Project toxicologist, I support project teams in executing translational strategies, demonstrating my commitment to innovative drug development.
With my proficiency in in vitro toxicology, cell biology, and in vivo pre-clinical studies, I have contributed significantly to the advancement of small molecule, oligo nucleotide, cell and gene therapy, gene editing and combination therapies targeting cardiovascular, renal, ocular, neurological and metabolic diseases. My previous experience as a Senior Research Scientist at Northern Biomedical Research has honed my skills in running studies compliant with FDA regulations, study monitoring, mentorship, and process improvement. These skills underscore my dedication to enhancing research methodologies and my pursuit of scientific excellence in the field of toxicology.